单细胞RNA测序揭示大型与巨型先天性黑色素细胞痣的转录组景观及潜在靶点
本研究对大型与巨型先天性黑色素细胞痣(L/GCMN)患者皮损、非皮损及健康皮肤进行单细胞与批量RNA测序,发现患者黑色素细胞密度增高、黑色素合成功能增强,TBX2是GCMN特异性黑色素细胞亚群的核心转录因子,并与黑色素细胞增殖和黑色素合成密切相关;同时检测到多效蛋白-蛋白酪氨酸磷酸酶受体Z1型及胰岛素样生长因子1(IGF-1)-IGF-1受体信号通路异常激活。
要点
- L/GCMN患者皮肤中黑色素细胞密度增高且黑色素合成相关功能增强。
- TBX2是GCMN特异性黑色素细胞亚群的核心转录因子,与增殖和黑色素合成相关。
- L/GCMN黑色素细胞中多效蛋白-PTPRZ1及IGF-1-IGF-1R信号通路异常激活。
核心结论
- 本研究初步揭示了L/GCMN的转录组景观和细胞相互作用网络,为深入探索其分子机制奠定基础。
研究设计与样本
- 研究采用单细胞与批量RNA测序分析L/GCMN患者皮损、非皮损及健康皮肤样本,并通过Western blotting、qRT-PCR、免疫组化和多重免疫荧光验证结果,同时分离原代痣黑色素细胞探索TBX2对其生物学功能的影响。
主要发现
- L/GCMN患者黑色素细胞密度更高,黑色素合成相关过程功能增强。
- TBX2是GCMN特异性表达黑色素细胞亚群的核心转录因子,与痣黑色素细胞增殖和黑色素合成密切相关。
- L/GCMN黑色素细胞中检测到多效蛋白-蛋白酪氨酸磷酸酶受体Z1型及IGF-1-IGF-1受体信号通路异常激活。
临床怎么用
- TBX2及异常激活的多效蛋白-PTPRZ1和IGF-1-IGF-1R信号通路可能作为L/GCMN未来非手术治疗开发的潜在靶点。
局限性
- L/GCMN为罕见复杂疾病,深入研究受限,未来需在更大患者群体中开展研究。
- 需进一步理解TBX2如何发挥作用,并寻找靶向本研究所发现异常细胞通讯通路的药物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The pathogenesis of large and giant congenital melanocytic naevi (L/GCMN) remains poorly understood, presenting significant challenges for its treatment. To date, no treatment guidelines for L/GCMN have been established. Moreover, single-cell technologies have not been applied in L/GCMN research, impeding an understanding of the disease at the cellular level. OBJECTIVES: To elaborate on the transcriptomic landscape of cells in the skin microenvironment of L/GCMN, explore the crucial molecular mechanisms of melanocyte pathological changes and investigate their interactions with other cells. METHODS: We used a combination of single-cell and bulk RNA sequencing of lesional and nonlesional skin samples from patients with L/GCMN and healthy skin samples. Moreover, we also conducted Western blotting, quantitative reverse transcription polymerase chain reaction, and immunohistochemical and multiplex immunofluorescence to validate our results. Additionally, we isolated primary naevomelanocytes and explored the impact of T-box transcription factor 2 (TBX2) on the biologic functions of naevomelanocytes. RESULTS: Patients with L/GCMN have a higher density of melanocytes and enhanced functions in melanin synthesis-related processes. TBX2 serves as a core transcription factor for a melanocyte subpopulation that is specifically expressed in GCMN. It is closely associated with the proliferation and melanin synthesis of naevomelanocytes. Additionally, abnormal activation of the pleiotrophin-protein tyrosine phosphatase receptor type Z1 and insulin-like growth factor 1 (IGF-1)-IGF-1 receptor signalling pathways was detected in L/GCMN melanocytes. CONCLUSIONS: The study provides initial insights into the transcriptional landscape and cellular interaction networks of L/GCMN, laying a foundation for further exploration of its molecular mechanisms. Large and giant congenital melanocytic naevus is a rare skin condition. ‘Naevus’ is pronounced ‘nee-vus’. ‘Congenital’ means it is present at birth or shortly afterwards, and ‘melanocytic’ means it is pigmented (or coloured). It is commonly known as a ‘birthmark’ or ‘mole’. It can have a significant impact on a person’s wellbeing, and in many cases can increase the risks of developing skin cancer. Surgery is the main approach to treatment, but it can significantly affect people’s daily lives. Surgery can also be impractical. To identify causes of the disease, researchers in China looked at skin samples or individual cells from patients with these birthmarks. We found that a protein called TBX2 is associated with how severe the disease is and its location on the body. TBX2’s role is as a key ‘switch’ that controls how some skin cells grow and produce a compound known as ‘melanin’. Melanin is responsible for the pigmentation of skin, hair and eyes. It is produced by a type of skin cells called melanocytes. The researchers also found disruptions in certain communication pathways in cells. As the disease is rare and complex, in-depth research on what causes it has been hampered. This study offers a valuable starting point for exploring new ways of treating it. Future research should try to understand how TBX2 exerts its effects. It should also aim to find drugs that target the affected cell communication pathways we identified in this study. This could lead to the development of non-surgical treatments to reduce pigmentation and improve the quality of life of people with the disease. This could replace the need for multiple surgeries. Studies in larger groups of patients is important.
引用
- Tan W, Chen Z, Xu M, et al. Single-cell RNA sequencing reveals the transcriptomic landscape of and potential targets for large and giant congenital melanocytic naevi. Br J Dermatol. 2026. PMID: 40974031. doi:10.1093/bjd/ljaf360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。